List of Tables
Table 1. Global Conjugate Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Conjugate Vaccine Market Value Comparison by End Users (2023-2029) & (US$ Million)
Table 3. Global Conjugate Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Conjugate Vaccine Sales (Million Unit) of Key Manufacturers (2018-2023)
Table 5. Global Conjugate Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Conjugate Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Conjugate Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Conjugate Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Conjugate Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Conjugate Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Conjugate Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Conjugate Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Conjugate Vaccine Sales by Region (2018-2023) & (Million Unit)
Table 18. Global Conjugate Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Conjugate Vaccine Sales by Region (2024-2029) & (Million Unit)
Table 20. Global Conjugate Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Conjugate Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Conjugate Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Conjugate Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Conjugate Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Conjugate Vaccine Sales by Country (2018-2023) & (Million Unit)
Table 27. North America Conjugate Vaccine Sales by Country (2024-2029) & (Million Unit)
Table 28. North America Conjugate Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Conjugate Vaccine Sales by Country (2018-2023) & (Million Unit)
Table 32. Europe Conjugate Vaccine Sales by Country (2024-2029) & (Million Unit)
Table 33. Europe Conjugate Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Conjugate Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Conjugate Vaccine Sales by Region (2018-2023) & (Million Unit)
Table 37. Asia Pacific Conjugate Vaccine Sales by Region (2024-2029) & (Million Unit)
Table 38. Asia Pacific Conjugate Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Conjugate Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Conjugate Vaccine Sales by Country (2018-2023) & (Million Unit)
Table 42. Latin America Conjugate Vaccine Sales by Country (2024-2029) & (Million Unit)
Table 43. Latin America Conjugate Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Conjugate Vaccine Sales by Country (2018-2023) & (Million Unit)
Table 47. Middle East & Africa Conjugate Vaccine Sales by Country (2024-2029) & (Million Unit)
Table 48. Middle East & Africa Conjugate Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Conjugate Vaccine Sales (Million Unit) by Type (2018-2023)
Table 51. Global Conjugate Vaccine Sales (Million Unit) by Type (2024-2029)
Table 52. Global Conjugate Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Conjugate Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Conjugate Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Conjugate Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Conjugate Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Conjugate Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Conjugate Vaccine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Conjugate Vaccine Price (USD/Unit) by Type (2024-2029)
Table 60. Global Conjugate Vaccine Sales (Million Unit) by End Users (2018-2023)
Table 61. Global Conjugate Vaccine Sales (Million Unit) by End Users (2024-2029)
Table 62. Global Conjugate Vaccine Sales Market Share by End Users (2018-2023)
Table 63. Global Conjugate Vaccine Sales Market Share by End Users (2024-2029)
Table 64. Global Conjugate Vaccine Revenue (US$ Million) by End Users (2018-2023)
Table 65. Global Conjugate Vaccine Revenue (US$ Million) by End Users (2024-2029)
Table 66. Global Conjugate Vaccine Revenue Market Share by End Users (2018-2023)
Table 67. Global Conjugate Vaccine Revenue Market Share by End Users (2024-2029)
Table 68. Global Conjugate Vaccine Price (USD/Unit) by End Users (2018-2023)
Table 69. Global Conjugate Vaccine Price (USD/Unit) by End Users (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Conjugate Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. GSK Conjugate Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Conjugate Vaccine Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Merck Conjugate Vaccine Product
Table 89. Merck Recent Developments/Updates
Table 90. Walvax Biotechnology Corporation Information
Table 91. Walvax Biotechnology Description and Business Overview
Table 92. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Walvax Biotechnology Conjugate Vaccine Product
Table 94. Walvax Biotechnology Recent Developments/Updates
Table 95. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 96. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 97. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 99. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
Table 100. Bharat Biotech Corporation Information
Table 101. Bharat Biotech Description and Business Overview
Table 102. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Bharat Biotech Conjugate Vaccine Product
Table 104. Bharat Biotech Recent Developments/Updates
Table 105. Zhifei Biologic Corporation Information
Table 106. Zhifei Biologic Description and Business Overview
Table 107. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Zhifei Biologic Conjugate Vaccine Product
Table 109. Zhifei Biologic Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Conjugate Vaccine Distributors List
Table 113. Conjugate Vaccine Customers List
Table 114. Conjugate Vaccine Market Trends
Table 115. Conjugate Vaccine Market Drivers
Table 116. Conjugate Vaccine Market Challenges
Table 117. Conjugate Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Conjugate Vaccine
Figure 2. Global Conjugate Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Conjugate Vaccine Market Share by Type in 2022 & 2029
Figure 4. Hib Vaccine Product Picture
Figure 5. Meningococcal Vaccine Product Picture
Figure 6. Pneumococcal Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Conjugate Vaccine Market Value Comparison by End Users (2023-2029) & (US$ Million)
Figure 9. Global Conjugate Vaccine Market Share by End Users in 2022 & 2029
Figure 10. Children
Figure 11. Adult
Figure 12. Global Conjugate Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Conjugate Vaccine Market Size (2018-2029) & (US$ Million)
Figure 14. Global Conjugate Vaccine Sales (2018-2029) & (Million Unit)
Figure 15. Global Conjugate Vaccine Average Price (USD/Unit) & (2018-2029)
Figure 16. Conjugate Vaccine Report Years Considered
Figure 17. Conjugate Vaccine Sales Share by Manufacturers in 2022
Figure 18. Global Conjugate Vaccine Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Conjugate Vaccine Players: Market Share by Revenue in 2022
Figure 20. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Conjugate Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 27. Europe Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 28. Germany Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Conjugate Vaccine Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Conjugate Vaccine Revenue Market Share by Region (2018-2029)
Figure 35. China Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 46. Latin America Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Conjugate Vaccine by Type (2018-2029)
Figure 56. Global Revenue Market Share of Conjugate Vaccine by Type (2018-2029)
Figure 57. Global Conjugate Vaccine Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Conjugate Vaccine by End Users (2018-2029)
Figure 59. Global Revenue Market Share of Conjugate Vaccine by End Users (2018-2029)
Figure 60. Global Conjugate Vaccine Price (USD/Unit) by End Users (2018-2029)
Figure 61. Conjugate Vaccine Value Chain
Figure 62. Conjugate Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed